115 related articles for article (PubMed ID: 19853188)
1. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
[TBL] [Abstract][Full Text] [Related]
2. A Cervical Cancer Screening Toolkit for Somali Women: A Pilot Randomized Controlled Trial.
Ghebrendrias S; Mody S; Washington S; Hussein B; Jama F; Jacobs M
J Immigr Minor Health; 2023 Dec; 25(6):1307-1314. PubMed ID: 37071376
[TBL] [Abstract][Full Text] [Related]
3. Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives.
Chen CC; Lai CH; Chang CL; Cheng WF; Pwu RF; Tsai J; Wang PH; Whang-Peng J; Lai GM
J Formos Med Assoc; 2023 Nov; 122(11):1213-1218. PubMed ID: 37451959
[TBL] [Abstract][Full Text] [Related]
4. It Is Time to Switch to Primary HPV Screening for Cervical Cancer.
Harper DM; Bettcher CM; Young AP
Am Fam Physician; 2024 Jan; 109(1):8-9. PubMed ID: 38227863
[No Abstract] [Full Text] [Related]
5. HPV Primary and Co-testing: An Ethical Analysis Exploring the Role of Cytology in Cervical Cancer Screening and Management.
Chiou PZ
J Allied Health; 2023; 52(4):301-304. PubMed ID: 38036477
[TBL] [Abstract][Full Text] [Related]
6. Association Analysis between Body Mass Index and Genomic DNA Methylation across 15 Major Cancer Types.
Gu Y; Zhang CW; Wang L; Zhao Y; Wang H; Ye Q; Gao S
J Cancer; 2018; 9(14):2532-2542. PubMed ID: 30026852
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.
Malagón T; Franco EL; Tejada R; Vaccarella S
Nat Rev Clin Oncol; 2024 May; ():. PubMed ID: 38760499
[TBL] [Abstract][Full Text] [Related]
8. Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
Rebolj M; Brentnall AR; Cuschieri K
Br J Cancer; 2024 May; 130(11):1733-1743. PubMed ID: 38615108
[TBL] [Abstract][Full Text] [Related]
9. Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study.
Grimes DR
BMJ Open; 2024 Feb; 14(2):e078551. PubMed ID: 38309749
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations.
Sørbye SW; Falang BM; Botha MH; Snyman LC; van der Merwe H; Visser C; Richter K; Dreyer G
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001713
[TBL] [Abstract][Full Text] [Related]
11. Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination.
Teoh D; Nam G; Aase DA; Russell R; Melton GB; Kulasingam S; Vogel RI
JAMA Netw Open; 2022 May; 5(5):e2214020. PubMed ID: 35612854
[TBL] [Abstract][Full Text] [Related]
12. Shifting from cytology to HPV testing for cervical cancer screening in Canada.
Delpero E; Selk A
CMAJ; 2022 May; 194(17):E613-E615. PubMed ID: 35500920
[No Abstract] [Full Text] [Related]
13. Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study.
Bao H; Ma L; Zhao Y; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wu J; Wang HJ
Cancer Commun (Lond); 2022 Mar; 42(3):191-204. PubMed ID: 35142100
[TBL] [Abstract][Full Text] [Related]
14. Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
Grimes DR; Corry EMA; Malagón T; O'Riain C; Franco EL; Brennan DJ
JAMA Netw Open; 2021 Jun; 4(6):e2115321. PubMed ID: 34190993
[TBL] [Abstract][Full Text] [Related]
15. Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening.
Paraskevaidi M; Cameron SJS; Whelan E; Bowden S; Tzafetas M; Mitra A; Semertzidou A; Athanasiou A; Bennett PR; MacIntyre DA; Takats Z; Kyrgiou M
EBioMedicine; 2020 Oct; 60():103017. PubMed ID: 32980699
[TBL] [Abstract][Full Text] [Related]
16. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
Kyrgiou M; Arbyn M; Bergeron C; Bosch FX; Dillner J; Jit M; Kim J; Poljak M; Nieminen P; Sasieni P; Kesic V; Cuzick J; Gultekin M
Br J Cancer; 2020 Aug; 123(4):510-517. PubMed ID: 32507855
[TBL] [Abstract][Full Text] [Related]
17. Impact of HPV vaccination on cervical screening performance: a population-based cohort study.
Lei J; Ploner A; Lehtinen M; Sparén P; Dillner J; Elfström KM
Br J Cancer; 2020 Jul; 123(1):155-160. PubMed ID: 32362659
[TBL] [Abstract][Full Text] [Related]
18. Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme.
Castanon A
J Med Screen; 2021 Jun; 28(2):80-87. PubMed ID: 32299280
[TBL] [Abstract][Full Text] [Related]
19. Projected time to elimination of cervical cancer in the USA: a comparative modelling study.
Burger EA; Smith MA; Killen J; Sy S; Simms KT; Canfell K; Kim JJ
Lancet Public Health; 2020 Apr; 5(4):e213-e222. PubMed ID: 32057315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
